
1 hr 3 min

Ovarian Cancer | Consensus or Controversy? Current and Future Management of Ovarian Cancer Research To Practice | Oncology Videos
-
- Science
Featuring perspectives from Drs Ursula Matulonis and Debra Richardson, including the following topics:
PROLOGUE: Antibody-Drug Conjugates Across Oncology (0:00) Antibody-Drug Conjugates in Ovarian Cancer: Mirvetuximab Soravtansine (10:03) Antibody-Drug Conjugates in Ovarian Cancer: Upifitamab Rilsodotin (29:09) Tumor Treating Fields (41:35) PARP Inhibitor Update (47:29) CME information and select publications
Featuring perspectives from Drs Ursula Matulonis and Debra Richardson, including the following topics:
PROLOGUE: Antibody-Drug Conjugates Across Oncology (0:00) Antibody-Drug Conjugates in Ovarian Cancer: Mirvetuximab Soravtansine (10:03) Antibody-Drug Conjugates in Ovarian Cancer: Upifitamab Rilsodotin (29:09) Tumor Treating Fields (41:35) PARP Inhibitor Update (47:29) CME information and select publications
1 hr 3 min